Loading…
miR-29b-3p suppresses the malignant biological behaviors of AML cells via inhibiting NF-κB and JAK/STAT signaling pathways by targeting HuR
Background HuR/ELAVL1 (embryonic lethal abnormal vision 1) was a downstream target of miR-29b in some cancer cells. HuR protein exerts important prognostic effects of involving in the pathogenesis and development of acute myeloid leukemia (AML). This study aims to investigate the role of miR-29b-3p...
Saved in:
Published in: | BMC cancer 2022-08, Vol.22 (1), p.1-909, Article 909 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c473t-a283a28df6a20440b90ce92cb083d2bf1870919fa1f9312a788e3ca2e4504d0c3 |
---|---|
cites | cdi_FETCH-LOGICAL-c473t-a283a28df6a20440b90ce92cb083d2bf1870919fa1f9312a788e3ca2e4504d0c3 |
container_end_page | 909 |
container_issue | 1 |
container_start_page | 1 |
container_title | BMC cancer |
container_volume | 22 |
creator | Tang, Yong-Jing Wu, Wei Chen, Qiao-Qian Liu, Shu-Han Zheng, Zhi-Yuan Cui, Zhao-Lei Xu, Jian-Ping Xue, Yan Lin, Dong-Hong |
description | Background HuR/ELAVL1 (embryonic lethal abnormal vision 1) was a downstream target of miR-29b in some cancer cells. HuR protein exerts important prognostic effects of involving in the pathogenesis and development of acute myeloid leukemia (AML). This study aims to investigate the role of miR-29b-3p in biological behaviors of AML cells by targeting HuR and the involvement of the NF-κB and JAK/STAT signaling pathways. Methods The expressions of HuR and miR-29b-3p in AML cells were determined using RT-qPCR and Western blot, and the association between them was analyzed using the Spearman method. Next, the target relationship between HuR and miR-29b-3p was predicted by biological information databases and verified by the dual-luciferase reporter gene assay. MTS, methyl cellulose, flow cytometry and transwell assay were employed to detect the cell proliferation, clone formation, cell cycle and apoptosis, invasion and migration respectively, the effect of miR-29b-3p targeted HuR on the biological behaviors of AML cells was explored after over- /down-expression of miR-29b-3p and rescue experiment. Then, immunofluorescence assay and western blot were employed to detect location expression and phosphorylation levels of NF-κB and JAK/STAT signaling pathways related molecules respectively. Results HuR was negatively correlated with miR-29b-3p, and was the downstream target of miR-29b-3p in AML cells. When miR-29b-3p was overexpressed in AML cells, HuR was down-regulated, accompanied by cell viability decreased, cell cycle arrest, apoptosis increased, invasion and migration weakened. Moreover, the opposite result appeared after miR-29b-3p was down-regulated. The rescue experiment showed that miR-29b-3p inhibitor could reverse the biological effect of HuR down-regulation in AML cells. Molecular pathway results showed that miR-29b-3p could inhibit p65 expression in nucleus and phosphorylation levels of p65, IκBα, STAT1, STAT3 and STAT5. Conclusion miR-29b-3p can inhibit malignant biological behaviors of AML cells via the inactivation of the NF-κB and JAK/STAT signaling pathways by targeting HuR. miR-29b-3p and its target HuR can be used as a new potential molecular for AML treatment. |
doi_str_mv | 10.1186/s12885-022-09996-1 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_a26e28b1459d4f469d922d2b6b456505</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_a26e28b1459d4f469d922d2b6b456505</doaj_id><sourcerecordid>2704867081</sourcerecordid><originalsourceid>FETCH-LOGICAL-c473t-a283a28df6a20440b90ce92cb083d2bf1870919fa1f9312a788e3ca2e4504d0c3</originalsourceid><addsrcrecordid>eNpdkstu1DAUhiMEohd4AVaW2LAJ9S2OvUEaKkoLA0hlWFvHiZN4lMSpnQyad-gT8RA8E8lMhSgLy5bP5-9YR3-SvCL4LSFSXERCpcxSTGmKlVIiJU-SU8JzklKO86f_nE-Ssxi3GJNcYvk8OWGZkoIRcprcd-42pcqkbEBxGoZgY7QRjY1FHbSu7qEfkXG-9bUroEXGNrBzPkTkK7T6skaFbduIdg6Q6xtn3Oj6Gn29Sn__eo-gL9Gn1eeL75vVBsVF1i7VAcbmJ-wjMns0Qqjt4c31dPsieVZBG-3Lh_08-XH1YXN5na6_fby5XK3TgudsTIFKNq-yEkAx59goXFhFC4MlK6mpiMyxIqoCUilGKORSWlYAtTzDvMQFO09ujt7Sw1YPwXUQ9tqD04cLH2oNYXRFazVQYak0hGeq5BUXqlSUzk2E4ZnIcDa73h1dw2Q6Wxa2HwO0j6SPK71rdO13WrHZlKlZ8OZBEPzdZOOoOxeXqUJv_RQ1zTGXIseSzOjr_9Ctn8I81YUiGVeZEGym6JEqgo8x2OrvZwjWS3D0MTh6Do4-BEcT9geFMbSY</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2715495663</pqid></control><display><type>article</type><title>miR-29b-3p suppresses the malignant biological behaviors of AML cells via inhibiting NF-κB and JAK/STAT signaling pathways by targeting HuR</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Tang, Yong-Jing ; Wu, Wei ; Chen, Qiao-Qian ; Liu, Shu-Han ; Zheng, Zhi-Yuan ; Cui, Zhao-Lei ; Xu, Jian-Ping ; Xue, Yan ; Lin, Dong-Hong</creator><creatorcontrib>Tang, Yong-Jing ; Wu, Wei ; Chen, Qiao-Qian ; Liu, Shu-Han ; Zheng, Zhi-Yuan ; Cui, Zhao-Lei ; Xu, Jian-Ping ; Xue, Yan ; Lin, Dong-Hong</creatorcontrib><description>Background HuR/ELAVL1 (embryonic lethal abnormal vision 1) was a downstream target of miR-29b in some cancer cells. HuR protein exerts important prognostic effects of involving in the pathogenesis and development of acute myeloid leukemia (AML). This study aims to investigate the role of miR-29b-3p in biological behaviors of AML cells by targeting HuR and the involvement of the NF-κB and JAK/STAT signaling pathways. Methods The expressions of HuR and miR-29b-3p in AML cells were determined using RT-qPCR and Western blot, and the association between them was analyzed using the Spearman method. Next, the target relationship between HuR and miR-29b-3p was predicted by biological information databases and verified by the dual-luciferase reporter gene assay. MTS, methyl cellulose, flow cytometry and transwell assay were employed to detect the cell proliferation, clone formation, cell cycle and apoptosis, invasion and migration respectively, the effect of miR-29b-3p targeted HuR on the biological behaviors of AML cells was explored after over- /down-expression of miR-29b-3p and rescue experiment. Then, immunofluorescence assay and western blot were employed to detect location expression and phosphorylation levels of NF-κB and JAK/STAT signaling pathways related molecules respectively. Results HuR was negatively correlated with miR-29b-3p, and was the downstream target of miR-29b-3p in AML cells. When miR-29b-3p was overexpressed in AML cells, HuR was down-regulated, accompanied by cell viability decreased, cell cycle arrest, apoptosis increased, invasion and migration weakened. Moreover, the opposite result appeared after miR-29b-3p was down-regulated. The rescue experiment showed that miR-29b-3p inhibitor could reverse the biological effect of HuR down-regulation in AML cells. Molecular pathway results showed that miR-29b-3p could inhibit p65 expression in nucleus and phosphorylation levels of p65, IκBα, STAT1, STAT3 and STAT5. Conclusion miR-29b-3p can inhibit malignant biological behaviors of AML cells via the inactivation of the NF-κB and JAK/STAT signaling pathways by targeting HuR. miR-29b-3p and its target HuR can be used as a new potential molecular for AML treatment.</description><identifier>ISSN: 1471-2407</identifier><identifier>EISSN: 1471-2407</identifier><identifier>DOI: 10.1186/s12885-022-09996-1</identifier><identifier>PMID: 35986311</identifier><language>eng</language><publisher>London: BioMed Central</publisher><subject>Acute myeloid leukemia ; Apoptosis ; Binding sites ; Cell cycle ; Cell growth ; Cell proliferation ; Cell viability ; Cellulose ; Embryos ; Flow cytometry ; Gene expression ; HuR ; HuR protein ; Immunofluorescence ; Infections ; Leukemia ; Malignant biological behaviors ; Manufacturers ; Membranes ; Methylcellulose ; MicroRNAs ; miR-29b-3p ; NF-κB and JAK/STAT signaling pathways ; NF-κB protein ; Pathogenesis ; Phosphorylation ; Plasmids ; Proteins ; Reporter gene ; Signal transduction ; Stat1 protein ; Stat3 protein ; Stat5 protein</subject><ispartof>BMC cancer, 2022-08, Vol.22 (1), p.1-909, Article 909</ispartof><rights>2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c473t-a283a28df6a20440b90ce92cb083d2bf1870919fa1f9312a788e3ca2e4504d0c3</citedby><cites>FETCH-LOGICAL-c473t-a283a28df6a20440b90ce92cb083d2bf1870919fa1f9312a788e3ca2e4504d0c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392259/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2715495663?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,25734,27905,27906,36993,36994,44571,53772,53774</link.rule.ids></links><search><creatorcontrib>Tang, Yong-Jing</creatorcontrib><creatorcontrib>Wu, Wei</creatorcontrib><creatorcontrib>Chen, Qiao-Qian</creatorcontrib><creatorcontrib>Liu, Shu-Han</creatorcontrib><creatorcontrib>Zheng, Zhi-Yuan</creatorcontrib><creatorcontrib>Cui, Zhao-Lei</creatorcontrib><creatorcontrib>Xu, Jian-Ping</creatorcontrib><creatorcontrib>Xue, Yan</creatorcontrib><creatorcontrib>Lin, Dong-Hong</creatorcontrib><title>miR-29b-3p suppresses the malignant biological behaviors of AML cells via inhibiting NF-κB and JAK/STAT signaling pathways by targeting HuR</title><title>BMC cancer</title><description>Background HuR/ELAVL1 (embryonic lethal abnormal vision 1) was a downstream target of miR-29b in some cancer cells. HuR protein exerts important prognostic effects of involving in the pathogenesis and development of acute myeloid leukemia (AML). This study aims to investigate the role of miR-29b-3p in biological behaviors of AML cells by targeting HuR and the involvement of the NF-κB and JAK/STAT signaling pathways. Methods The expressions of HuR and miR-29b-3p in AML cells were determined using RT-qPCR and Western blot, and the association between them was analyzed using the Spearman method. Next, the target relationship between HuR and miR-29b-3p was predicted by biological information databases and verified by the dual-luciferase reporter gene assay. MTS, methyl cellulose, flow cytometry and transwell assay were employed to detect the cell proliferation, clone formation, cell cycle and apoptosis, invasion and migration respectively, the effect of miR-29b-3p targeted HuR on the biological behaviors of AML cells was explored after over- /down-expression of miR-29b-3p and rescue experiment. Then, immunofluorescence assay and western blot were employed to detect location expression and phosphorylation levels of NF-κB and JAK/STAT signaling pathways related molecules respectively. Results HuR was negatively correlated with miR-29b-3p, and was the downstream target of miR-29b-3p in AML cells. When miR-29b-3p was overexpressed in AML cells, HuR was down-regulated, accompanied by cell viability decreased, cell cycle arrest, apoptosis increased, invasion and migration weakened. Moreover, the opposite result appeared after miR-29b-3p was down-regulated. The rescue experiment showed that miR-29b-3p inhibitor could reverse the biological effect of HuR down-regulation in AML cells. Molecular pathway results showed that miR-29b-3p could inhibit p65 expression in nucleus and phosphorylation levels of p65, IκBα, STAT1, STAT3 and STAT5. Conclusion miR-29b-3p can inhibit malignant biological behaviors of AML cells via the inactivation of the NF-κB and JAK/STAT signaling pathways by targeting HuR. miR-29b-3p and its target HuR can be used as a new potential molecular for AML treatment.</description><subject>Acute myeloid leukemia</subject><subject>Apoptosis</subject><subject>Binding sites</subject><subject>Cell cycle</subject><subject>Cell growth</subject><subject>Cell proliferation</subject><subject>Cell viability</subject><subject>Cellulose</subject><subject>Embryos</subject><subject>Flow cytometry</subject><subject>Gene expression</subject><subject>HuR</subject><subject>HuR protein</subject><subject>Immunofluorescence</subject><subject>Infections</subject><subject>Leukemia</subject><subject>Malignant biological behaviors</subject><subject>Manufacturers</subject><subject>Membranes</subject><subject>Methylcellulose</subject><subject>MicroRNAs</subject><subject>miR-29b-3p</subject><subject>NF-κB and JAK/STAT signaling pathways</subject><subject>NF-κB protein</subject><subject>Pathogenesis</subject><subject>Phosphorylation</subject><subject>Plasmids</subject><subject>Proteins</subject><subject>Reporter gene</subject><subject>Signal transduction</subject><subject>Stat1 protein</subject><subject>Stat3 protein</subject><subject>Stat5 protein</subject><issn>1471-2407</issn><issn>1471-2407</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkstu1DAUhiMEohd4AVaW2LAJ9S2OvUEaKkoLA0hlWFvHiZN4lMSpnQyad-gT8RA8E8lMhSgLy5bP5-9YR3-SvCL4LSFSXERCpcxSTGmKlVIiJU-SU8JzklKO86f_nE-Ssxi3GJNcYvk8OWGZkoIRcprcd-42pcqkbEBxGoZgY7QRjY1FHbSu7qEfkXG-9bUroEXGNrBzPkTkK7T6skaFbduIdg6Q6xtn3Oj6Gn29Sn__eo-gL9Gn1eeL75vVBsVF1i7VAcbmJ-wjMns0Qqjt4c31dPsieVZBG-3Lh_08-XH1YXN5na6_fby5XK3TgudsTIFKNq-yEkAx59goXFhFC4MlK6mpiMyxIqoCUilGKORSWlYAtTzDvMQFO09ujt7Sw1YPwXUQ9tqD04cLH2oNYXRFazVQYak0hGeq5BUXqlSUzk2E4ZnIcDa73h1dw2Q6Wxa2HwO0j6SPK71rdO13WrHZlKlZ8OZBEPzdZOOoOxeXqUJv_RQ1zTGXIseSzOjr_9Ctn8I81YUiGVeZEGym6JEqgo8x2OrvZwjWS3D0MTh6Do4-BEcT9geFMbSY</recordid><startdate>20220820</startdate><enddate>20220820</enddate><creator>Tang, Yong-Jing</creator><creator>Wu, Wei</creator><creator>Chen, Qiao-Qian</creator><creator>Liu, Shu-Han</creator><creator>Zheng, Zhi-Yuan</creator><creator>Cui, Zhao-Lei</creator><creator>Xu, Jian-Ping</creator><creator>Xue, Yan</creator><creator>Lin, Dong-Hong</creator><general>BioMed Central</general><general>BMC</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20220820</creationdate><title>miR-29b-3p suppresses the malignant biological behaviors of AML cells via inhibiting NF-κB and JAK/STAT signaling pathways by targeting HuR</title><author>Tang, Yong-Jing ; Wu, Wei ; Chen, Qiao-Qian ; Liu, Shu-Han ; Zheng, Zhi-Yuan ; Cui, Zhao-Lei ; Xu, Jian-Ping ; Xue, Yan ; Lin, Dong-Hong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c473t-a283a28df6a20440b90ce92cb083d2bf1870919fa1f9312a788e3ca2e4504d0c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Acute myeloid leukemia</topic><topic>Apoptosis</topic><topic>Binding sites</topic><topic>Cell cycle</topic><topic>Cell growth</topic><topic>Cell proliferation</topic><topic>Cell viability</topic><topic>Cellulose</topic><topic>Embryos</topic><topic>Flow cytometry</topic><topic>Gene expression</topic><topic>HuR</topic><topic>HuR protein</topic><topic>Immunofluorescence</topic><topic>Infections</topic><topic>Leukemia</topic><topic>Malignant biological behaviors</topic><topic>Manufacturers</topic><topic>Membranes</topic><topic>Methylcellulose</topic><topic>MicroRNAs</topic><topic>miR-29b-3p</topic><topic>NF-κB and JAK/STAT signaling pathways</topic><topic>NF-κB protein</topic><topic>Pathogenesis</topic><topic>Phosphorylation</topic><topic>Plasmids</topic><topic>Proteins</topic><topic>Reporter gene</topic><topic>Signal transduction</topic><topic>Stat1 protein</topic><topic>Stat3 protein</topic><topic>Stat5 protein</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tang, Yong-Jing</creatorcontrib><creatorcontrib>Wu, Wei</creatorcontrib><creatorcontrib>Chen, Qiao-Qian</creatorcontrib><creatorcontrib>Liu, Shu-Han</creatorcontrib><creatorcontrib>Zheng, Zhi-Yuan</creatorcontrib><creatorcontrib>Cui, Zhao-Lei</creatorcontrib><creatorcontrib>Xu, Jian-Ping</creatorcontrib><creatorcontrib>Xue, Yan</creatorcontrib><creatorcontrib>Lin, Dong-Hong</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>BMC cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tang, Yong-Jing</au><au>Wu, Wei</au><au>Chen, Qiao-Qian</au><au>Liu, Shu-Han</au><au>Zheng, Zhi-Yuan</au><au>Cui, Zhao-Lei</au><au>Xu, Jian-Ping</au><au>Xue, Yan</au><au>Lin, Dong-Hong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>miR-29b-3p suppresses the malignant biological behaviors of AML cells via inhibiting NF-κB and JAK/STAT signaling pathways by targeting HuR</atitle><jtitle>BMC cancer</jtitle><date>2022-08-20</date><risdate>2022</risdate><volume>22</volume><issue>1</issue><spage>1</spage><epage>909</epage><pages>1-909</pages><artnum>909</artnum><issn>1471-2407</issn><eissn>1471-2407</eissn><abstract>Background HuR/ELAVL1 (embryonic lethal abnormal vision 1) was a downstream target of miR-29b in some cancer cells. HuR protein exerts important prognostic effects of involving in the pathogenesis and development of acute myeloid leukemia (AML). This study aims to investigate the role of miR-29b-3p in biological behaviors of AML cells by targeting HuR and the involvement of the NF-κB and JAK/STAT signaling pathways. Methods The expressions of HuR and miR-29b-3p in AML cells were determined using RT-qPCR and Western blot, and the association between them was analyzed using the Spearman method. Next, the target relationship between HuR and miR-29b-3p was predicted by biological information databases and verified by the dual-luciferase reporter gene assay. MTS, methyl cellulose, flow cytometry and transwell assay were employed to detect the cell proliferation, clone formation, cell cycle and apoptosis, invasion and migration respectively, the effect of miR-29b-3p targeted HuR on the biological behaviors of AML cells was explored after over- /down-expression of miR-29b-3p and rescue experiment. Then, immunofluorescence assay and western blot were employed to detect location expression and phosphorylation levels of NF-κB and JAK/STAT signaling pathways related molecules respectively. Results HuR was negatively correlated with miR-29b-3p, and was the downstream target of miR-29b-3p in AML cells. When miR-29b-3p was overexpressed in AML cells, HuR was down-regulated, accompanied by cell viability decreased, cell cycle arrest, apoptosis increased, invasion and migration weakened. Moreover, the opposite result appeared after miR-29b-3p was down-regulated. The rescue experiment showed that miR-29b-3p inhibitor could reverse the biological effect of HuR down-regulation in AML cells. Molecular pathway results showed that miR-29b-3p could inhibit p65 expression in nucleus and phosphorylation levels of p65, IκBα, STAT1, STAT3 and STAT5. Conclusion miR-29b-3p can inhibit malignant biological behaviors of AML cells via the inactivation of the NF-κB and JAK/STAT signaling pathways by targeting HuR. miR-29b-3p and its target HuR can be used as a new potential molecular for AML treatment.</abstract><cop>London</cop><pub>BioMed Central</pub><pmid>35986311</pmid><doi>10.1186/s12885-022-09996-1</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1471-2407 |
ispartof | BMC cancer, 2022-08, Vol.22 (1), p.1-909, Article 909 |
issn | 1471-2407 1471-2407 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_a26e28b1459d4f469d922d2b6b456505 |
source | Publicly Available Content Database; PubMed Central |
subjects | Acute myeloid leukemia Apoptosis Binding sites Cell cycle Cell growth Cell proliferation Cell viability Cellulose Embryos Flow cytometry Gene expression HuR HuR protein Immunofluorescence Infections Leukemia Malignant biological behaviors Manufacturers Membranes Methylcellulose MicroRNAs miR-29b-3p NF-κB and JAK/STAT signaling pathways NF-κB protein Pathogenesis Phosphorylation Plasmids Proteins Reporter gene Signal transduction Stat1 protein Stat3 protein Stat5 protein |
title | miR-29b-3p suppresses the malignant biological behaviors of AML cells via inhibiting NF-κB and JAK/STAT signaling pathways by targeting HuR |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T17%3A09%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=miR-29b-3p%20suppresses%20the%20malignant%20biological%20behaviors%20of%20AML%20cells%20via%20inhibiting%20NF-%CE%BAB%20and%20JAK/STAT%20signaling%20pathways%20by%20targeting%20HuR&rft.jtitle=BMC%20cancer&rft.au=Tang,%20Yong-Jing&rft.date=2022-08-20&rft.volume=22&rft.issue=1&rft.spage=1&rft.epage=909&rft.pages=1-909&rft.artnum=909&rft.issn=1471-2407&rft.eissn=1471-2407&rft_id=info:doi/10.1186/s12885-022-09996-1&rft_dat=%3Cproquest_doaj_%3E2704867081%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c473t-a283a28df6a20440b90ce92cb083d2bf1870919fa1f9312a788e3ca2e4504d0c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2715495663&rft_id=info:pmid/35986311&rfr_iscdi=true |